CN117800655A - A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature - Google Patents
A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature Download PDFInfo
- Publication number
- CN117800655A CN117800655A CN202410022244.3A CN202410022244A CN117800655A CN 117800655 A CN117800655 A CN 117800655A CN 202410022244 A CN202410022244 A CN 202410022244A CN 117800655 A CN117800655 A CN 117800655A
- Authority
- CN
- China
- Prior art keywords
- chitosan
- hydroxyapatite
- printing
- potassium
- precision
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 83
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 title claims abstract description 72
- 229910052588 hydroxylapatite Inorganic materials 0.000 title claims abstract description 70
- 238000000034 method Methods 0.000 title claims abstract description 48
- 238000010146 3D printing Methods 0.000 title claims abstract description 43
- 239000002131 composite material Substances 0.000 title claims abstract description 31
- 238000001125 extrusion Methods 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 14
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002002 slurry Substances 0.000 claims abstract description 10
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims abstract description 8
- 239000011591 potassium Substances 0.000 claims abstract description 8
- 229910052700 potassium Inorganic materials 0.000 claims abstract description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 78
- 238000007639 printing Methods 0.000 claims description 48
- 238000003756 stirring Methods 0.000 claims description 16
- 229910021641 deionized water Inorganic materials 0.000 claims description 14
- 239000011268 mixed slurry Substances 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 8
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical group [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 2
- 239000011575 calcium Substances 0.000 claims description 2
- 229910052791 calcium Inorganic materials 0.000 claims description 2
- 230000006196 deacetylation Effects 0.000 claims description 2
- 238000003381 deacetylation reaction Methods 0.000 claims description 2
- 239000011574 phosphorus Substances 0.000 claims description 2
- 229910052698 phosphorus Inorganic materials 0.000 claims description 2
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 claims description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims description 2
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 claims description 2
- 229910001950 potassium oxide Inorganic materials 0.000 claims description 2
- OTYBMLCTZGSZBG-UHFFFAOYSA-L potassium sulfate Chemical compound [K+].[K+].[O-]S([O-])(=O)=O OTYBMLCTZGSZBG-UHFFFAOYSA-L 0.000 claims description 2
- 229910052939 potassium sulfate Inorganic materials 0.000 claims description 2
- 235000011151 potassium sulphates Nutrition 0.000 claims description 2
- 239000000758 substrate Substances 0.000 claims description 2
- 238000001132 ultrasonic dispersion Methods 0.000 claims 1
- 238000000465 moulding Methods 0.000 abstract description 10
- 238000005245 sintering Methods 0.000 abstract description 6
- 238000004132 cross linking Methods 0.000 abstract description 5
- 238000005507 spraying Methods 0.000 abstract description 3
- 230000004048 modification Effects 0.000 abstract description 2
- 238000012986 modification Methods 0.000 abstract description 2
- 239000011148 porous material Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000000243 solution Substances 0.000 description 19
- 239000000725 suspension Substances 0.000 description 11
- 239000000499 gel Substances 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 238000012805 post-processing Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 235000010413 sodium alginate Nutrition 0.000 description 3
- 239000000661 sodium alginate Substances 0.000 description 3
- 229940005550 sodium alginate Drugs 0.000 description 3
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000004108 freeze drying Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 235000012209 glucono delta-lactone Nutrition 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000004575 stone Substances 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- NPYPAHLBTDXSSS-UHFFFAOYSA-N Potassium ion Chemical compound [K+] NPYPAHLBTDXSSS-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 229910052586 apatite Inorganic materials 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229960003681 gluconolactone Drugs 0.000 description 1
- 238000003837 high-temperature calcination Methods 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000000462 isostatic pressing Methods 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000002114 nanocomposite Substances 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000000110 selective laser sintering Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000003980 solgel method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000013268 sustained release Methods 0.000 description 1
- 239000012730 sustained-release form Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B26/00—Compositions of mortars, concrete or artificial stone, containing only organic binders, e.g. polymer or resin concrete
- C04B26/02—Macromolecular compounds
- C04B26/28—Polysaccharides or derivatives thereof
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y70/00—Materials specially adapted for additive manufacturing
- B33Y70/10—Composites of different types of material, e.g. mixtures of ceramics and polymers or mixtures of metals and biomaterials
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2111/00—Mortars, concrete or artificial stone or mixtures to prepare them, characterised by specific function, property or use
- C04B2111/00034—Physico-chemical characteristics of the mixtures
- C04B2111/00181—Mixtures specially adapted for three-dimensional printing (3DP), stereo-lithography or prototyping
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Ceramic Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Structural Engineering (AREA)
- Civil Engineering (AREA)
- Composite Materials (AREA)
- Organic Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
技术领域Technical field
本发明属于材料科学工程领域,涉及一种高精度互连多孔结构羟基磷灰石/壳聚糖复合材料及室温一步法3D打印成型方法,在水处理、生物医用支架等领域具有一定的应用价值。The invention belongs to the field of materials science engineering and relates to a high-precision interconnected porous structure hydroxyapatite/chitosan composite material and a room temperature one-step 3D printing molding method. It has certain application value in the fields of water treatment, biomedical stents and other fields. .
背景技术Background technique
羟基磷灰石被广泛认可为出色的支架材料,然而传统的制备方法,如发泡法、烧结微球法和溶胶-凝胶法,通常需要高温煅烧,制备过程复杂,不便于负载生物活性药物。不同于传统方法,现代3D打印技术采用选择性激光烧结,将羟基磷灰石与低熔点物质混合,然而,所得支架通常存在形状不佳的问题,需要额外处理,如等静压来以提高密度,整个制备过程昂贵且复杂,同时难以负载生物活性物质。Hydroxyapatite is widely recognized as an excellent scaffold material. However, traditional preparation methods, such as foaming method, sintered microsphere method and sol-gel method, usually require high-temperature calcination, the preparation process is complicated, and it is not convenient to load bioactive drugs. . Unlike traditional methods, modern 3D printing technology uses selective laser sintering to mix hydroxyapatite with low-melting point substances. However, the resulting scaffolds often suffer from poor shape and require additional processing, such as isostatic pressing, to increase density. , the entire preparation process is expensive and complicated, and it is difficult to load biologically active substances.
其他3D打印方法(光固化、喷墨、直写挤出)通常是将羟基磷灰石粉末与高分子材料混合后进行挤出打印。尽管直写挤出式3D打印在生物医学领域具有良好的生物相容性和可实现多材料定制打印的明显优势,但当前可获得的3D打印直写挤出沉积技术通常需要在打印过程中进行喷淋、在打印后进行浸泡或者利用紫外光固化等工艺步骤。华南农业大学的刘水凤发表的3D打印构建羟基磷灰石/聚合物纳米复合生物多孔支架中利用以海藻酸钠(SA)、羟基磷灰石(HAP)和葡萄糖酸内酯(GDL)作为主要原料,使海藻酸钠原位凝胶化形成水凝胶作为生物墨水,通过挤出式3D打印方法获得凝胶支架,再将支架二次浸泡在氯化钙溶液中进行交联以提高支架性能。这些工序容易导致打印过程的结构控制性较差,精度较低,并且由于材料的原因,支架本身的机械性能也较差,从而限制了3D打印材料在相关领域的应用发展。Other 3D printing methods (light curing, inkjet, direct writing extrusion) usually mix hydroxyapatite powder with polymer materials and then perform extrusion printing. Although direct-write extrusion 3D printing has obvious advantages in biomedical fields such as good biocompatibility and the ability to achieve multi-material custom printing, currently available 3D printing direct-write extrusion deposition technologies often require in-process deposition during the printing process. Process steps such as spraying, soaking after printing or using UV light to cure. Liu Shuifeng of South China Agricultural University published a 3D printed hydroxyapatite/polymer nanocomposite bioporous scaffold using sodium alginate (SA), hydroxyapatite (HAP) and gluconolactone (GDL) as the main raw materials. , the sodium alginate is gelled in situ to form a hydrogel as a bioink, and the gel scaffold is obtained through the extrusion 3D printing method. The scaffold is then soaked in a calcium chloride solution for a second time for cross-linking to improve the performance of the scaffold. These processes can easily lead to poor structural control and low precision in the printing process, and due to the material, the mechanical properties of the stent itself are also poor, thus limiting the application and development of 3D printing materials in related fields.
因此,期望开发出一种室温下挤出3D打印材料和一步法成型工艺,该材料无生物毒性,无需后交联处理,具有高成型精度的三维结构上,以期在水处理和生物医学领域的有一定的应用。Therefore, it is expected to develop a room temperature extrusion 3D printing material and a one-step molding process that is non-biotoxic, does not require post-cross-linking treatment, and has a high molding accuracy on a three-dimensional structure, with a view to its application in the fields of water treatment and biomedicine. There are certain applications.
发明内容Contents of the invention
本发明针对目前羟基磷灰石类支架在3D打印的各类技术中存在设备、用料成本较高、后处理工序繁琐以及存在潜在有害生物毒性风险等技术问题,提出了一种高精度互连多孔结构掺钾羟基磷灰石/壳聚糖复合支架室温一步法3D打印成型方法。通过充分利用钾离子的缓释作用,并调控配方中的组分和工艺过程参数,本发明制备了一种可注射性强、固化时间适中的可3D打印浆料。这一过程可在常温挤出成形、无须烧结,也无需交联后处理,最终得到一种高精度互连多空结构的3D打印支架材料。The present invention proposes a high-precision interconnection method in view of the technical problems of current hydroxyapatite-based scaffolds in various 3D printing technologies, such as high equipment and material costs, cumbersome post-processing procedures, and the risk of potential harmful biological toxicity. One-step room temperature 3D printing method for porous structure potassium-doped hydroxyapatite/chitosan composite scaffold. By making full use of the sustained release effect of potassium ions and regulating the components and process parameters in the formula, the present invention prepares a 3D printable slurry with strong injectability and moderate curing time. This process can be extruded at room temperature without sintering or cross-linking post-processing, and ultimately results in a 3D printed scaffold material with a high-precision interconnected porous structure.
本发明的技术方案:Technical solution of the present invention:
一种高精度互连多孔结构羟基磷灰石/壳聚糖复合支架室温一步法3D打印成型方法,由掺钾羟基磷灰石粉体与壳聚糖配制成羟基磷灰石壳聚糖混合浆料,将羟基磷灰石壳聚糖混合浆料常温挤出3D打印自固结成形,得到羟基磷灰石/壳聚糖支架材料。A one-step 3D printing method for a high-precision interconnected porous structure hydroxyapatite/chitosan composite scaffold at room temperature is disclosed. Potassium-doped hydroxyapatite powder and chitosan are prepared into a hydroxyapatite-chitosan mixed slurry, and the hydroxyapatite-chitosan mixed slurry is extruded at room temperature for 3D printing and self-consolidation to obtain a hydroxyapatite/chitosan scaffold material.
所述掺钾羟基磷灰石粉体中的钙+钾与磷的摩尔比为5:3;钾按氧化钾计算在掺钾羟基磷灰石粉体中的质量占比为10~25wt%。The molar ratio of calcium + potassium to phosphorus in the potassium-doped hydroxyapatite powder is 5:3; the mass proportion of potassium in the potassium-doped hydroxyapatite powder is 10 to 25 wt% calculated as potassium oxide.
其中,钾盐为碳酸钾或硫酸钾或氢氧化钾。Among them, the potassium salt is potassium carbonate, potassium sulfate or potassium hydroxide.
所述掺钾羟基磷灰石粉体的微观形貌纳米级,长为20~100nm,宽为5~10nm。The microscopic morphology of the potassium-doped hydroxyapatite powder is nanoscale, with a length of 20 to 100 nm and a width of 5 to 10 nm.
由掺钾羟基磷灰石粉体与壳聚糖配制成羟基磷灰石壳聚糖混合浆料,具体为:先将掺钾羟基磷灰石粉体加入去离子水中超声分散,形成掺钾羟基磷灰石浆料;再将壳聚糖溶解于乙酸溶液中得到壳聚糖溶液;逐滴将掺钾羟基磷灰石浆料加入到壳聚糖溶液中,温度为30~75℃、转数为600~1000rpm的磁力搅拌机中搅拌,得到羟基磷灰石壳聚糖混合浆料。A hydroxyapatite-chitosan mixed slurry is prepared from potassium-doped hydroxyapatite powder and chitosan. The specific steps are: first, add potassium-doped hydroxyapatite powder to deionized water and disperse it ultrasonically to form potassium-doped hydroxyapatite. Apatite slurry; then dissolve chitosan in an acetic acid solution to obtain a chitosan solution; add the potassium-doped hydroxyapatite slurry to the chitosan solution drop by drop at a temperature of 30 to 75°C and a rotational speed of Stir in a magnetic stirrer at 600 to 1000 rpm to obtain a hydroxyapatite-chitosan mixed slurry.
所述的羟基磷灰石壳聚糖混合浆料中,壳聚糖和掺钾羟基磷灰石的质量比为1:1~1:2。In the hydroxyapatite-chitosan mixed slurry, the mass ratio of chitosan and potassium-doped hydroxyapatite is 1:1 to 1:2.
所述壳聚糖的脱乙酰度为80~95%;壳聚糖溶液中壳聚糖质量浓度为1~8%,乙酸的质量浓度2~6%。The deacetylation degree of the chitosan is 80-95%; the mass concentration of chitosan in the chitosan solution is 1-8%, and the mass concentration of acetic acid is 2-6%.
所述搅拌时长为2.5~4.5h。The stirring time is 2.5~4.5h.
所述3D打印的挤出头的直径为0.2~1.2mm,打印的层高为0.1~0.6mm,打印的速度为0.1mm/s~50mm/s,打印的气压为30~800kPa。The diameter of the 3D printing extrusion head is 0.2~1.2mm, the printing layer height is 0.1~0.6mm, the printing speed is 0.1mm/s~50mm/s, and the printing air pressure is 30~800kPa.
所述掺钾羟基磷灰石均匀的分布在互连多孔结构的内部及表面。The potassium-doped hydroxyapatite is uniformly distributed inside and on the surface of the interconnected porous structure.
无需在固化溶液中打印,也无需喷淋固化液等交联处理,免烧结等高温处理。其中,打印环境的温度保持室温,打印后需在打印基板上放置5~15min。There is no need to print in a curing solution, cross-linking treatment such as spraying the curing solution, or high-temperature treatment such as sintering. Among them, the temperature of the printing environment should be kept at room temperature, and it should be placed on the printing substrate for 5 to 15 minutes after printing.
本发明的有益效果:本发明提供一种高精度连续多孔结构掺钾羟基磷灰石/壳聚糖复合材料室温一步法3D打印成型方法,从羟基磷灰石的改性出发,获得羟基磷灰石/壳聚糖复合浆料的可注射性和凝固时间可调,使得浆体能够被用于直写式3D打印,并以此获得成形良好高精度的工程支架。Beneficial effects of the present invention: The present invention provides a high-precision continuous porous structure potassium-doped hydroxyapatite/chitosan composite material room temperature one-step 3D printing molding method. Starting from the modification of hydroxyapatite, hydroxyapatite is obtained The injectability and adjustable setting time of the stone/chitosan composite slurry allow the slurry to be used for direct-write 3D printing, thereby obtaining well-formed and high-precision engineering scaffolds.
具体包括以下几个方面:Specifically including the following aspects:
(1)将掺钾羟基磷灰石引入复合体系中,显著改善了浆体的可注射性(90%以上)、均匀性。通过掺钾羟基磷灰石中钾离子释放浓度的调控和壳聚糖组成配比及工艺的调控,提供了适配3D打印的加工窗口。本发明的制备方法采用常温一步挤出打印自固化成形,无需高能束辅助烧结(如激光、电子束),也无需紫外光辅助固化,更不需后续排胶、高温烧结等其他复杂后处理步骤,为羟基磷灰石在骨组织工程支架和水处理中的3D打印提供了新的便捷途径。(1) The introduction of potassium-doped hydroxyapatite into the composite system significantly improves the injectability (more than 90%) and uniformity of the slurry. By regulating the concentration of potassium ion release in potassium-doped hydroxyapatite and regulating the composition ratio and process of chitosan, a processing window suitable for 3D printing is provided. The preparation method of the present invention adopts one-step extrusion printing and self-curing molding at room temperature, without the need for high-energy beam-assisted sintering (such as laser, electron beam), nor does it require ultraviolet light-assisted curing, and does not require subsequent debinding, high-temperature sintering and other complex post-processing steps, which provides a new and convenient way for 3D printing of hydroxyapatite in bone tissue engineering scaffolds and water treatment.
(2)本发明中采用的羟基磷灰石和壳聚糖具有高安全性和良好的生物相容性。所打印的骨支架具有合适的孔隙率和孔径结构,有利于骨组织的生长,从而使得该支架具有出色的生物相容性及骨传导性。互连多孔结构孔洞结构有利于营养物质的输运、血管的生长,并能促进细胞的附着、增值、分化。(2) The hydroxyapatite and chitosan used in the present invention have high safety and good biocompatibility. The printed bone scaffold has appropriate porosity and pore size structure, which is conducive to the growth of bone tissue, making the scaffold have excellent biocompatibility and osteoconductivity. The interconnected porous structure is conducive to the transportation of nutrients, the growth of blood vessels, and can promote cell attachment, proliferation, and differentiation.
(3)本发明制备的掺钾羟基磷灰石/壳聚糖复合支架材料是在室温左右的条件下打印完成3D打印,这种低温的3D打印技术有助于支架的养护和成分亲和性,避免污染。相较于同打印后需要高温烧结或高温打印的产品,具有更高的活性优势。(3) The potassium-doped hydroxyapatite/chitosan composite scaffold material prepared by the present invention is 3D printed at about room temperature. This low-temperature 3D printing technology is helpful for the maintenance and component affinity of the scaffold. , to avoid pollution. Compared with products that require high-temperature sintering or high-temperature printing after printing, it has a higher activity advantage.
(4)本发明采用的常温一步成形工艺有利于载药和高活性因子,甚至活性细胞的亲和添加,使得支架能够具有更高的生物活性。(4) The one-step forming process at room temperature used in the present invention is beneficial to the loading of drugs, highly active factors, and even the affinity addition of active cells, enabling the scaffold to have higher biological activity.
附图说明Description of drawings
图1是实施例1中所得试样。基本不能够成型,极易坍塌融合,基本无法打印,打印后很快融合塌陷,无法得到实用的支架材料。Figure 1 is a sample obtained in Example 1. It is basically impossible to form, it is easy to collapse and fuse, and it is basically impossible to print. It fuses and collapses quickly after printing, making it impossible to obtain a practical scaffold material.
图2是实施例2所得试样;其中,(a)为所得试样精度较高,(b)为将(a)放置一段时间后,层层分明仍然保持较高精度。Figure 2 shows the sample obtained in Example 2; where (a) shows that the sample obtained has higher precision, and (b) shows that after (a) is placed for a period of time, the layers are clear and still maintain high precision.
图3是实施例3所得试样。Figure 3 is a sample obtained in Example 3.
图4是实施例6所得试样;其中,(a)为打印试样某些节点会产生一定的融合,整体成型质量尚可;(b)为成型后试样很快塌陷融合,精度较差。Figure 4 is the sample obtained in Example 6; among them, (a) some nodes of the printed sample will produce a certain degree of fusion, and the overall molding quality is acceptable; (b) the sample collapses and fuses quickly after molding, and the accuracy is poor. .
具体实施方式Detailed ways
以下结合附图和技术方案,进一步说明本发明的具体实施方式。The specific embodiments of the present invention will be further described below in conjunction with the accompanying drawings and technical solutions.
实施例1Example 1
将2g壳聚糖溶于3wt%(乙酸的浓度)的乙酸水溶液中,使用磁力搅拌器进行在60℃、800rpm下搅拌,制备了5w%浓度的壳聚糖乙酸溶液。将3.0g不掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液逐滴加入壳聚糖乙酸溶液中,壳聚糖和不掺钾羟基磷灰石质量比为2:3,继续搅拌3h,得到混合均匀的掺钾羟基磷灰石壳聚糖悬浊液。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为400kPa。所得试样基本不能够成型,极易坍塌融合,基本无法打印(如图1所示),打印后很快融合塌陷,无法得到实用的支架材料。2g chitosan was dissolved in 3wt% (concentration of acetic acid) acetic acid aqueous solution, and a magnetic stirrer was used to stir at 60°C and 800rpm to prepare a chitosan acetic acid solution with a concentration of 5w%. 3.0g of undoped potassium hydroxyapatite was mixed with deionized water and ultrasonicated for 10-20 minutes using an ultrasonic cell disruptor to make it evenly dispersed. The potassium-doped hydroxyapatite suspension was added dropwise to the chitosan acetic acid solution, with a chitosan and undoped potassium hydroxyapatite mass ratio of 2:3, and continued to stir for 3h to obtain a uniformly mixed potassium-doped hydroxyapatite chitosan suspension. The composite gel ink was printed using a DIW printer, and the printing process conditions were that the diameter of the 3D printing extruder was 0.3mm, the printing layer height was 0.3mm, the printing speed was 30mm/s, and the printing pressure was 400kPa. The obtained sample was basically unable to be formed, was very easy to collapse and fuse, and was basically unable to be printed (as shown in Figure 1). It quickly fused and collapsed after printing, and no practical scaffold material could be obtained.
实施例2Example 2
将2g壳聚糖溶于3wt%(乙酸的浓度)的乙酸水溶液中,剧烈搅拌至澄清透明,制备了5wt%浓度的壳聚糖凝胶墨水。将3g掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液滴加入壳聚糖墨水中,壳聚糖和掺钾羟基磷灰石质量比为2:3,继续搅拌3h,得到掺钾羟基磷灰石壳聚糖复合墨水。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为400kPa。所得试样精度较高,见图2(a),放置一段时间后,层层分明仍然保持较高精度,见图2(b)。而后进行冷冻干燥,即可得到掺钾羟基磷灰石/壳聚糖复合支架。Dissolve 2g of chitosan in an acetic acid aqueous solution of 3wt% (concentration of acetic acid), and stir vigorously until it is clear and transparent, to prepare a chitosan gel ink with a concentration of 5wt%. Mix 3 g of potassium-doped hydroxyapatite with deionized water, and use an ultrasonic cell disrupter to sonicate for 10-20 minutes to disperse evenly. Add the potassium-doped hydroxyapatite suspension droplets into the chitosan ink. The mass ratio of chitosan and potassium-doped hydroxyapatite is 2:3. Continue stirring for 3 hours to obtain the potassium-doped hydroxyapatite chitosan composite. ink. Use a DIW printer to print the composite gel ink. The printing process conditions are as follows: the diameter of the 3D printing extrusion head is 0.3mm, the printing layer height is 0.3mm, the printing speed is 30mm/s, and the printing air pressure is 400kPa. The obtained sample has high precision, as shown in Figure 2(a). After being placed for a period of time, the layers are clearly separated and still maintains high precision, as shown in Figure 2(b). Then freeze-drying is performed to obtain the potassium-doped hydroxyapatite/chitosan composite scaffold.
实施例3Example 3
将2g壳聚糖溶于3wt%(乙酸的浓度)的乙酸水溶液中,使用磁力搅拌器进行在60℃、800rpm下搅拌,制备了5w%浓度的壳聚糖乙酸溶液。将6g掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液逐滴加入壳聚糖乙酸溶液中,壳聚糖和掺钾羟基磷灰石质量比为1:3,继续搅拌3h,得到混合均匀的掺钾羟基磷灰石壳聚糖悬浊液。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为400kPa。如图3所示,不能实现打印成型。Dissolve 2 g of chitosan in an acetic acid aqueous solution of 3 wt% (concentration of acetic acid) and stir using a magnetic stirrer at 60° C. and 800 rpm to prepare a chitosan acetic acid solution with a concentration of 5 wt%. Mix 6 g of potassium-doped hydroxyapatite with deionized water, and use an ultrasonic cell disrupter to sonicate for 10-20 minutes to disperse evenly. Add the potassium-doped hydroxyapatite suspension dropwise into the chitosan acetic acid solution. The mass ratio of chitosan to potassium-doped hydroxyapatite is 1:3. Continue stirring for 3 hours to obtain a uniformly mixed potassium-doped hydroxyapatite. Chitosan suspension. Use a DIW printer to print the composite gel ink. The printing process conditions are as follows: the diameter of the 3D printing extrusion head is 0.3mm, the printing layer height is 0.3mm, the printing speed is 30mm/s, and the printing air pressure is 400kPa. As shown in Figure 3, printing and molding cannot be achieved.
实施例4Example 4
将2.0g壳聚糖溶于2wt%(乙酸的浓度)的乙酸水溶液中,使用磁力搅拌器进行在60℃、800rpm下搅拌,制备了5w%浓度的壳聚糖乙酸溶液。将4.0g掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液逐滴加入壳聚糖乙酸溶液中,壳聚糖和掺钾羟基磷灰石质量比为1:2,继续搅拌3h,得到混合均匀的掺钾羟基磷灰石壳聚糖悬浊液。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为350kPa。所得试样成型完整。而后进行冷冻干燥,即可得到掺钾羟基磷灰石/壳聚糖复合支架。Dissolve 2.0 g of chitosan in an acetic acid aqueous solution of 2 wt% (concentration of acetic acid) and stir using a magnetic stirrer at 60° C. and 800 rpm to prepare a chitosan acetic acid solution with a concentration of 5 wt%. Mix 4.0 g of potassium-doped hydroxyapatite with deionized water, and use an ultrasonic cell disrupter to sonicate for 10-20 minutes to disperse evenly. Add the potassium-doped hydroxyapatite suspension dropwise into the chitosan acetic acid solution. The mass ratio of chitosan and potassium-doped hydroxyapatite is 1:2. Continue stirring for 3 hours to obtain a uniformly mixed potassium-doped hydroxyapatite. Chitosan suspension. Use a DIW printer to print the composite gel ink. The printing process conditions are as follows: the diameter of the 3D printing extrusion head is 0.3mm, the printing layer height is 0.3mm, the printing speed is 30mm/s, and the printing air pressure is 350kPa. The obtained specimens were formed completely. Then freeze-drying is performed to obtain the potassium-doped hydroxyapatite/chitosan composite scaffold.
实施例5Example 5
将2.0g壳聚糖溶于2wt%(乙酸的浓度)的乙酸水溶液中,使用磁力搅拌器进行在60℃、800rpm下搅拌,制备了5w%浓度的壳聚糖乙酸溶液。将2.0g掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液逐滴加入壳聚糖乙酸溶液中,壳聚糖和掺钾羟基磷灰石质量比为1:1,继续搅拌5h,得到混合均匀的掺钾羟基磷灰石壳聚糖悬浊液。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为800kPa。所得试样成型完整,打印过程中流畅性有一定限制,打印成型试样精度较高。而后进行冷冻干燥,即可得到掺钾羟基磷灰石/壳聚糖复合支架。2.0g chitosan was dissolved in 2wt% (concentration of acetic acid) acetic acid aqueous solution, and a magnetic stirrer was used to stir at 60℃ and 800rpm to prepare a chitosan acetic acid solution with a concentration of 5w%. 2.0g potassium-doped hydroxyapatite was mixed with deionized water and ultrasonicated for 10-20 minutes using an ultrasonic cell disruptor to make it evenly dispersed. The potassium-doped hydroxyapatite suspension was added dropwise to the chitosan acetic acid solution, and the mass ratio of chitosan to potassium-doped hydroxyapatite was 1:1. Stirring was continued for 5h to obtain a uniformly mixed potassium-doped hydroxyapatite chitosan suspension. The composite gel ink was printed using a DIW printer. The printing process conditions were that the diameter of the 3D printing extruder was 0.3mm, the printing layer height was 0.3mm, the printing speed was 30mm/s, and the printing pressure was 800kPa. The obtained sample was completely formed, the fluency was limited during the printing process, and the printed sample had high precision. Then freeze-dried to obtain a potassium-doped hydroxyapatite/chitosan composite scaffold.
实施例6Example 6
将2g壳聚糖溶于3wt%(乙酸的浓度)的乙酸水溶液中,使用磁力搅拌器进行在60℃、800rpm下搅拌,制备了5w%浓度的壳聚糖乙酸溶液。将2.0g不掺钾羟基磷灰石与去离子水混合,使用超声波细胞破碎仪超声10-20分钟,使其分散均匀。将掺钾羟基磷灰石悬浊液逐滴加入壳聚糖乙酸溶液中,壳聚糖和不掺钾羟基磷灰石质量比为1:1,继续搅拌3h,得到混合均匀的掺钾羟基磷灰石壳聚糖悬浊液。使用DIW打印机将复合凝胶墨水打印,打印的工艺条件为3D打印的挤出头的直径为0.3mm,打印的层高为0.3mm,打印的速度为30mm/s,打印的气压为400kPa。打印试样某些节点会产生一定的融合,整体成型质量尚可,见图4(a)。成型后试样很快塌陷融合,精度较差,见图4(b)。Dissolve 2 g of chitosan in an acetic acid aqueous solution of 3 wt% (concentration of acetic acid) and stir using a magnetic stirrer at 60° C. and 800 rpm to prepare a chitosan acetic acid solution with a concentration of 5 wt%. Mix 2.0g of potassium-free hydroxyapatite with deionized water, and use an ultrasonic cell disrupter to sonicate for 10-20 minutes to disperse evenly. Add the potassium-doped hydroxyapatite suspension dropwise into the chitosan acetic acid solution. The mass ratio of chitosan to non-potassium hydroxyapatite is 1:1. Continue stirring for 3 hours to obtain a uniformly mixed potassium-doped hydroxyapatite solution. Gray stone chitosan suspension. Use a DIW printer to print the composite gel ink. The printing process conditions are as follows: the diameter of the 3D printing extrusion head is 0.3mm, the printing layer height is 0.3mm, the printing speed is 30mm/s, and the printing air pressure is 400kPa. Some nodes of the printed sample will produce a certain degree of fusion, and the overall molding quality is acceptable, as shown in Figure 4(a). After forming, the sample collapsed and fused quickly, with poor accuracy, as shown in Figure 4(b).
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410022244.3A CN117800655A (en) | 2024-01-08 | 2024-01-08 | A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202410022244.3A CN117800655A (en) | 2024-01-08 | 2024-01-08 | A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature |
Publications (1)
Publication Number | Publication Date |
---|---|
CN117800655A true CN117800655A (en) | 2024-04-02 |
Family
ID=90430148
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202410022244.3A Pending CN117800655A (en) | 2024-01-08 | 2024-01-08 | A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117800655A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118178719A (en) * | 2024-05-20 | 2024-06-14 | 贝兴悦(成都)科技有限公司 | Hydroxyapatite composite hydrogel and preparation method and application thereof |
-
2024
- 2024-01-08 CN CN202410022244.3A patent/CN117800655A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN118178719A (en) * | 2024-05-20 | 2024-06-14 | 贝兴悦(成都)科技有限公司 | Hydroxyapatite composite hydrogel and preparation method and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Wang et al. | 3D printing of bone tissue engineering scaffolds | |
CN105727368B (en) | A kind of three-dimensional composite material bracket and preparation method thereof | |
DE102006029298B4 (en) | Material system for 3D printing, process for its production, granules made from the material system and its use | |
KR101929661B1 (en) | Injectable composition for filler comprising porous biodegradable microspheres and water soluble natural polymers | |
Gao et al. | High-strength hydrogel-based bioinks | |
Monfared et al. | A deep insight into the preparation of ceramic bone scaffolds utilizing robocasting technique | |
CN117800655A (en) | A one-step 3D printing method for high-precision interconnected porous hydroxyapatite/chitosan composite scaffold at room temperature | |
CN107041971A (en) | A kind of fibroin based on 3 D-printing/gelatin timbering material and preparation method thereof | |
EP3034101B1 (en) | Biological implant | |
CN101015712A (en) | Process for preparation of polycaprolactone-chitosan network/hydroxyapatite porous compound support frame material | |
CN107744601A (en) | A kind of 3 D-printing wound covering material based on silk microballoon bio-ink and preparation method thereof | |
CN105330285A (en) | A ZrO2 toughened bioactive ceramic powder material for 3D printing and its preparation and application | |
Li et al. | Fabrication of mesoporous calcium silicate/calcium phosphate cement scaffolds with high mechanical strength by freeform fabrication system with micro-droplet jetting | |
AU2018374827B2 (en) | Water-soluble salt particle containing compositions and porous materials made therefrom | |
CN107823712A (en) | A kind of method for preparing imitative artificial bone of coral with cuttlebone and products thereof | |
Shi et al. | Fabrication, properties, and biomedical applications of calcium-containing cellulose-based composites | |
CN112206353A (en) | Chitin whisker liquid crystal elastomer modified polylactic acid composite material and preparation method and application thereof | |
US8431623B2 (en) | Process for forming a porous PVA scaffold using a pore-forming agent | |
Qin et al. | Preparation and characterization of different micro/nano structures on the surface of bredigite scaffolds | |
CN113582680A (en) | Hydroxyapatite ceramic and preparation method and application thereof | |
CN118405672A (en) | Preparation method of porous hydroxyapatite | |
Wang et al. | Polycaprolactone strengthening gelatin/nano-hydroxyapatite composite biomaterial inks for potential application in extrusion-based 3D printing bone scaffolds | |
CN110680954A (en) | A kind of 3D printing xanthan gum hydrogel scaffold and preparation method thereof | |
Fiume et al. | Processing of bioactive glass scaffolds for bone tissue engineering | |
Tahmasebifar et al. | Polysaccharide-based 3D bioprinter inks for tissue engineering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |